Skip to main content

Amazon, JPMorgan, Berkshire Hathaway name new CEO in quest to fix health care

Amazon, JPMorgan, and Berkshire Hathaway are taking the next step in their U.S. employee nonprofit health care business by naming a new chief executive officer. On Wednesday, the powerhouse trio announced the appointment of Atul Gawande as the new leader of the business.

While the company does not yet have a name, Gawande’s name lends additional credibility to the venture. The well-known surgeon and author boasts an impressive résumé — he is a professor at the Harvard T.H. Chan School of Public Health and Harvard Medical School, and has penned four New York Times best-sellers. In his new role as CEO, he will be leading a company that is independent “from profit-making incentives and constraints,” the companies noted in a press release.

Related Videos

“I’m thrilled to be named CEO of this health care initiative,” said Atul, “I have devoted my public health career to building scalable solutions for better health care delivery that are saving lives, reducing suffering, and eliminating wasteful spending both in the U.S. and across the world. Now I have the backing of these remarkable organizations to pursue this mission with even greater impact for more than a million people, and in doing so incubate better models of care for all. This work will take time but must be done. The system is broken, and better is possible.”

In working together, Amazon, JPMorgan, andBerkshire Hathaway are hoping they can deliver health care better than the current players in the game. Unfortunately, details are still extremely sparse when it comes to exactly what the three titans have in mind. When the nonprofit was first announced in January, the trio said it was with the goal of finding “ways to address health care for their U.S. employees, with the aim of improving employee satisfaction and reducing costs.”

So how exactly did Gawande land the job? Apparently, 10 candidates were interviewed, and were “asked to write a white paper on how they would fix the health care system.” Ultimately, three individuals made the final cut, and from there, Gawande was chosen.

“Talent and dedication were manifest among the many professionals we interviewed,” said Berkshire Hathaway Chairman and CEO, Warren Buffett. “All felt that better care can be delivered and that rising costs can be checked. [JPMorgan CEO] Jamie [Dimon], [Amazon CEO] Jeff [Bezos], and I are confident that we have found in Atul the leader who will get this important job done.”

The joint venture will be headquartered in Boston (which is ideal for Gawande, who is already based in the New England metropolis), and the new CEO’s duties will begin July 9.

Editors' Recommendations

Lyft-Circulation partnership takes the hassle out of your doctor visit

Going to the doctor is already a chore in and of itself -- after all, chances are that you're coughing, sniffling, or otherwise uncomfortable when you finally decide to do the responsible thing and give your health care professional a call. So the last thing you want is a troublesome commute to your doctor's office. Enter a new partnership between on-demand, non-emergency health care transportation startup Circulation and ridesharing giant Lyft. The two companies are hoping to make your next trip to the doctor as painless as possible.

Beginning Tuesday, December 5, Circulation users can schedule Lyft rides through Circulation's digital transportation platform. While these rides obviously aren't meant for emergency situations (you'll need to call an actual ambulance with actual medical professionals for those situations), for all other scenarios, the new Lyft partnership is said to expand Circulation's coverage to clients nationwide, and help bring patients to more than 1,000 health care facilities.

Read more
Will Amazon soon sell you generic prescription drugs?
prescription drugs

One of the world's largest online retailers may be getting into the healthcare industry. CNBC reports that Amazon is in "high level" talks with industry representatives regarding prescription drugs. Anonymous sources report that Amazon has been in talks with Mylan and the Sandoz branch of Novartis. A note from Leerink bank confirmed that the Sandoz meeting happened. Both of these companies are fairly large players in the generic prescription drug industry.

This is hardly the first time that Amazon has expressed an interest in entering the healthcare industry. Earlier this year, it was reported that Amazon was hiring personnel to help it enter the healthcare field, and that the company has a license to sell medical equipment.

Read more
Amazon Fresh spoils in several markets, shuts down in all but the biggest cities
amazon fresh suspends service pickup

Amazon may feel like an unstoppable force, what with its incredible inertia as it expands across the fashion, food, and even delivery industries. But every once in awhile, it seems, even giants can be brought to a heel. Despite the online retailer's recent steps forward in the food arena -- as evidenced by its Whole Foods acquisition and rumored meal kits -- it would appear that a longer-standing component of the company's business isn't faring quite so well. As initially reported by Recode, Amazon Fresh, the grocery delivery service, is closing in at least nine states. So if you've enjoyed not having to go to your grocery store, you may have to look toward an alternative delivery solution.

For folks living in New Jersey, Pennsylvania, Delaware, Maryland, California, New York, Connecticut, Massachusetts, and Virginia, receiving a notification noting that Amazon Fresh is no longer delivering in their neighborhoods may seem like quite a shock. After all, the service was first launched a decade ago in Seattle, and has since grown to service a considerable proportion of the U.S. Now, however, it would appear that Amazon is rolling back its long-standing grocery service.

Read more